Boekhorst Paul Francis Olivier te bought $76k of ICCC
President and CEO at IMMUCELL CORP /DE/. 8,000 shares at an average of $9.50, traded Jun 18, 2026, filed Jun 22, 2026.
Score components
- +25RoleCEO
- +8Trade size$76k at market
- +10Relative to holdingsHoldings up 82%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-021258, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | POpen-market purchase Common Stock, par value $.01 per share | +8,000 | $9.50 | $76k | 17,785 | Jun 22, 2026 |
Related signals
Other insiders at IMMUCELL CORP /DE/ and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 53Moderate | IMMUCELL CORP /DE/ | Boekhorst Paul Francis Olivier te President and CEO | $32k 6,030 shares | +163% | |
| 48Moderate | IMMUCELL CORP /DE/ | Boekhorst Paul Francis Olivier te President and CEO | $49k 9,785 shares | - | |
| 26Weak | IMMUCELL CORP /DE/ | David Scott Tomsche director | $16k 3,266 shares | +6% | |
| 23Weak | ICCCbuy IMMUCELL CORP /DE/ | Bryan K. Gathagan director | $6,320 1,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.